Balyasny Asset Management L.P.
Position in VNDA — Vanda Pharmaceuticals Inc.
CIK 1218710
Chicago, IL
Position in VNDA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$397,353
-$328,811 QoQ
Shares Held
64,927
-38.2% QoQ
Ownership
0.107%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#66
of 172 holders
Holding Since
Mar 2020
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VNDA Over Time
Shares Held
Position Value (USD)
Derivatives in VNDA
reported options exposure · as of Dec 31, 2020CallValue
$0
CallShares
250,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Balyasny Asset Management L.P. holds $2,350,910,046 across 177 Biotechnology names. VNDA ranks #157 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
1,665,102 | $221,008,988 | |
| 2 | INSM |
INSMED Inc
|
1,326,430 | $141,423,966 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,230,052 | $91,614,272 | |
| 4 | ABVX |
Abivax S.A.
|
603,840 | $80,467,718 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
145,005 | $72,028,333 | |
| 6 | TNGX |
Tango Therapeutics, Inc.
|
2,016,379 | $63,032,007 | |
| 7 | CYTK |
Cytokinetics Inc
|
711,676 | $60,627,678 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
1,054,613 | $60,344,955 |
All Filings in VNDA
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $397,353 | 64,927 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $726,164 | 105,089 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $601,329 | 68,178 | Shares | Sole | 2026-02-17 | |
| 2025-03-31 | $113,345 | 24,694 | Shares | Sole | 2025-05-15 | |
| 2023-09-30 | $678,900 | 157,153 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $67,804 | 10,289 | Shares | Other | 2023-08-14 | |
| 2022-12-31 | $296,250 | 40,088 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $99,965 | 10,118 | Shares | Sole | 2022-11-15 | |
| 2021-06-30 ALXN | — | 771,620 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 ALXN | — | 800,344 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 ALXN | — | 250,000 | Call | Sole | 2021-02-16 | |
| 2020-12-31 ALXN | — | 329,802 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 ALXN | — | 80,000 | Put | Sole | 2020-11-16 | |
| 2020-09-30 ALXN | — | 170,000 | Call | Sole | 2020-11-16 | |
| 2020-09-30 ALXN | — | 316,028 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 ALXN | — | 146,522 | Shares | Sole | 2020-08-14 | |
| 2020-06-30 ALXN | — | 50,000 | Call | Sole | 2020-08-14 | |
| 2020-03-31 ALXN | — | 50,000 | Call | Sole | 2020-05-15 | |
| 2020-03-31 ALXN | — | 96,219 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||